AstraZeneca in $560 m deal for respiratory firm
Jun 10, 2013 | Posted by: roboblogger | Full story: Seattle Times
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Since: Apr 13
This sounds promising.
Add your comments below
|CA Judge overturns California's ban on same-sex ma... (Aug '10)||52 min||what up doc||200,578|
|Ron Fleishman is the World's Most Underrated Ph...||7 hr||Twin||3|
|CA California seeks to ban free, single-use carryo... (Jun '10)||9 hr||Bee Keepers||4,977|
|CA California Proposition 19: the Marijuana Legali... (Oct '10)||15 hr||facts faced||15,929|
|Border Agents Make Zero-Tolerance Zone (Aug '06)||19 hr||guest||48|
|Google, Oracle Enlisted to Help Fix Obamacare Site (Nov '13)||Tue||Just Thinking||8|